Regulatory News
Thursday, February 2, 2017
BRIEF-Teva confirms generic Victoza patent challenge in the United States
* Teva confirms generic Victoza patent challenge in the
united states
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment